← Leaderboards
Daniel S Perrien
Vanderbilt University
$5,036,905
Attributed
$6,342,624
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,342,624 · 5
VA$0 · 1
By mechanism
R01$5,087,584 · 2
S10$874,000 · 2
R21$381,040 · 1
IK2$0 · 1
Top collaborators
- Edward C Hsiao4 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Curtis Lee Gabriel$640,790
- Nikki Cheng$4,462,144
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventSignal TransductionOsteogenesisProgressive Myositis OssificansMacrophageCessation Of LifeJointsPainMuscleResponseHeterotopic OssificationFlareCytokineCellsImmobilizationInflammatoryImmuneInflammationPoint MutationMonocyteSkeletal MuscleMyelogenousActivin AIn Vitro
Grant awards (19)
the Gut Microbiome as a Disease Modifier of Heterotopic Ossification$640,847
R01 · FY2025 · AR · contact PI
the Gut Microbiome as a Disease Modifier of Heterotopic Ossification$640,847
R01 · FY2024 · AR · contact PI
the Gut Microbiome as a Disease Modifier of Heterotopic Ossification$660,666
R01 · FY2023 · AR · contact PI
the Gut Microbiome as a Disease Modifier of Heterotopic Ossification$669,078
R01 · FY2022 · AR · contact PI
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva$419,429
R01 · FY2022 · AR · contact PI
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva$118,095
R01 · FY2022 · AR · contact PI
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva$423,905
R01 · FY2021 · AR · contact PI
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva$118,095
R01 · FY2021 · AR · contact PI
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva$443,285
R01 · FY2020 · AR · contact PI
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva$98,414
R01 · FY2020 · AR · contact PI
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva$404,004
R01 · FY2019 · AR · contact PI
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva$450,919
R01 · FY2018 · AR · contact PI
Immune cells and cytokines mediating fibrodysplasia ossificans progressiva$173,800
R21 · FY2016 · AR · contact PI
Immune cells and cytokines mediating fibrodysplasia ossificans progressiva$207,240
R21 · FY2015 · AR · contact PI
Interventions and Mechanisms of Disuse Osteopenia$0
IK2 · FY2015 · VA · contact PI
vivaCT80 - in vivo small animal microCT$414,000
S10 · FY2014 · OD · contact PI
Interventions and Mechanisms of Disuse Osteopenia$0
IK2 · FY2014 · VA · contact PI
Interventions and Mechanisms of Disuse Osteopenia$0
IK2 · FY2013 · VA · contact PI
Novel ultrahigh resolution microCT imaging system$460,000
S10 · FY2010 · RR · contact PI